Involvement of KL-6 Biomarker in Interstitial Lung Disease Induced by SARS-CoV-2 Infection: A Systematic Review

Early prognosis of severe disease and preventive actions hang around as the mainstay in managing the novel SARS-COV-2 outbreak due to the lack of robust therapeutic strategies. Krebs von den Lungen-6 (KL-6 or KL-6/MUC1) is a relatively new discovered transmembrane mucoprotein that was shown to be a...

Full description

Bibliographic Details

Published in:	Applied Sciences
Main Authors:	Radu Crisan-Dabija, Adrian Covic, Crischentian Brinza, Iolanda Valentina Popa, Alexandru Burlacu
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Subjects:	interstitial lung disease SARS-CoV-2 COVID-19 KL-6 disease severity prognostic biomarkers
Online Access:	https://www.mdpi.com/2076-3417/11/8/3482